WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
US Stock Market Move | GCL Global (GCL.US) surges over 7% and will hold an earnings conference call on January 30th.
US Stock Market Move | Stock price continues to rise! Telefonaktiebolaget LM Ericsson Sponsored ADR Class B (ERIC.US) is up over 4%.
On January 27, EDIANYUN (02416) spent 6.0868 million Hong Kong dollars to repurchase 2.096 million shares.
US Stock Market Move | GCL Global (GCL.US) surges over 7% and will hold an earnings conference call on January 30th.
US Stock Market Move | Stock price continues to rise! Telefonaktiebolaget LM Ericsson Sponsored ADR Class B (ERIC.US) is up over 4%.
On January 27, EDIANYUN (02416) spent 6.0868 million Hong Kong dollars to repurchase 2.096 million shares.
RECOMMEND
New Record Achieved As Spot Gold Tops $5,000 For The First Time; Institutions Set $6,600 Target
27/01/2026
117 Companies Raised Over HKD 285.6 Billion Through IPOs As Hong Kong Reclaims Global Leadership In 2025
27/01/2026
“A+H Hong Kong Listing Requires RMB 30 Billion Market Cap”? On‑Site Inquiry Dispels The Rumor
27/01/2026
